Melatonin in human breast cancer tissue: Association with nuclear grade and estrogen receptor status

Laboratory Investigation

Volumn 75, Issue 4, 1996, Pages 557-561

  Maestroni, Georges J M ^a   Conti, Ario ^a  

^a INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MELATONIN;

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INHIBITION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; PRIORITY JOURNAL; PROGNOSIS; TISSUE LEVEL; TUMOR GROWTH;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL NUCLEUS; FEMALE; HUMANS; MELATONIN; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0029909061     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bartsch C and Bartsch H (1993). Melatonin secretion in oncological patients: Current results and methodological considerations. In: Maestroni GJM, Conti A, and Reiter R, editors. Advances in pineal research 7. London: John Libbey, 283-301.
2. Ben-Nathan D, Maestroni GJM, and Conti A (1995). Protective effect of melatonin in mice infected with encephalitis viruses. Arch Virol 140:223-230.
3. Blask DE (1993). Melatonin in oncology. In: Yu H-S and Reiter R, editors. Melatonin: Biosynthesis, physiological effects, and clinical applications. Boca Raton, Florida: CRC Press, 447-477.
4. Blask DE (1984). The pineal: An oncostatic gland? In: Reiter R, editor. The pineal gland. New York: Raven Press, 253-285.
5. Caroleo MC, Frasca D, Nistico G, and Doria G (1992). Melatonin as immunomodulator in immunodeficient mice. Immunopharmacology 23:81-89.
6. Champney TH and McMurray DN (1991). Spleen morphology and lymphoproliferative activity in short photoperiod exposed hamsters. In: Fraschini F and Reiter R, editors. Role of melatonin and pineal peptides in neuroimmunomodulation. London: Plenum, 219-225.
7. Colombo LL, Chen G-J, Lopez MC, and Watson RR (1992). Melatonin induced increase in gamma-interferon production by murine splenocytes. Immunol Lett 33:123-126.
8. Conti A and Maestroni GJM (1995). The clinical neuroimmunotherapeutic role of melatonin in oncology. J Pineal Res 19:103-110.
9. Conti A and Maestroni GJM (1996). HPLC validation of melatonin circadian rhythm in the pineal gland of inbred mice. J Pineal Res 20:138-144.
10. Danforth DN, Tamarkin L, and Lippman ME (1983). Melatonin increases oestrogen receptor binding activity of human breast cancer cells. Nature 305:323-325.
11. Iguchi H, Kato H, and Ibayashi H (1982). Age-dependent reduction in serum melatonin concentrations in healthy subjects. J Clin Endocrinol Metab 55:27-32.
12. Maestroni GJM (1993). The immunoneuroendocrine role of melatonin. J Pineal Res 14:1-10.
13. Maestroni GJM, Conti A, and Lissoni P (1994a). Colony-stimulating activity and hematopoietic rescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin 4. Cancer Res 54:4740-4743.
14. Maestroni GJM, Covacci V, and Conti A (1994b). Hematopoietic rescue via T-cell-dependent, endogenous GM-CSF by the pineal neurohormone melatonin in tumor bearing mice. Cancer Res 54:2429-2432.
15. McGrath PC, Holley DT, Hamby LS, Powell DE, Mattingly C, and Freeman JW (1994). Proliferation-associated nucleolar antigen P120: A prognostic marker in node-negative breast cancer. Surgery 116:616-620.
16. Morrey MK, McLachlan JA, Serkin CD, and Bakouche O (1994). Activation of human monocytes by the pineal neurohormone melatonin. J Immunol 153:2671-2680.
17. Pioli C, Caroleo MC, Nistico G, and Doria G (1993). Melatonin increases antigen presentation and amplifies specific and non-specific signals for T-cell proliferation. Int J Immunopharmacol 15:463-469.
18. Vorkapic P, Waldhauser F, Bruckner R, Biegelmayer C, Schmidbauer M, and Pendl G (1987). Serum melatonin levels: A new neurodiagnostic tool in pineal region tumors? Neurosurgery 21:817-824.
19. Yu H-S, Tsin ATC, and Reiter RJ (1993). Melatonin: History, biosynthesis, and assay methodology. In: Yu H-S and Reiter R, editors. Melatonin: Biosynthesis, physiological effects, and clinical applications. Boca Raton, Florida: CRC Press, 1-17.
20. Zava DT, Wyler-Von Ballmoos A, Goldhirsh A, Roos W, Takahashi A, Eppenberger U, Arrenbrecht S, Martz G, Losa G, Gomez F, and Guelpa C (1982). A quality control study to assess the inter-laboratory variability of routine estrogen and and progesterone receptor assays. Eur J Clin Oncol 18:713-721.